Our Team.

Sara has over 20 years of experience advancing medicines that improve patient outcomes in oncology, autoimmune diseases, and neuroscience. She has held leadership roles in both global pharma companies and innovative startups. Most recently, as Chief of Staff to the CEO and Head of Commercialization at Sana Biotechnology, Sara focused on the development of transformative cell and gene therapies. Prior to Sana, Sara led the global commercialization of a COVID antibody and oversaw U.S. Cell Therapy Franchise marketing at Bristol Myers Squibb. She also served as Vice President for Doctor On Demand’s Health Plan and Employer Business Unit and led corporate strategy initiatives at Amgen. Sara began her career at Eli Lilly, where she built a strong operational foundation through her sales, marketing, six sigma black belt, and management roles. Sara is recognized for building patient-centered, high-performing teams. She holds an MBA from Xavier University and a BS in Management from the University of Wisconsin-Stout.